Use of a native epitope for selecting evolved binding members from a library of mutants of a protein capable of binding to said epitope
The invention provides a method for selecting at least one member from a library of proteinaceous molecules by providing at least one cell and/or a functional equivalent thereof, with at least part of the library under conditions that allow binding of any such member to an epitope in and/or on the cells and/or the functional equivalent thereof, removing unbound proteinaceous molecules and selecting the at least one member, wherein the library includes at least one mutant of a proteinaceous molecule capable of binding to the epitope.
1. A molecule that binds to Ep-CAM, said molecule comprising a human heavy chain variable CDR3 region consisting of the amino acid sequence DPFLHY (SEQ ID NO: 6).
2. The molecule of claim 1 , further comprising a human light chain variable CDR3 region, the CDR3 region consisting of the amino acid sequence MQALQTFTF (SEQ ID NO: 7).
3. The molecule of claim 1 , characterized in that the molecule has an affinity constant for human Ep-CAM that is less than 5.0 nM.
4. The molecule of claim 1 , characterized in that the molecule has an affinity constant for human Ep-CAM that is between 5.0 nM and 0.4 nM.
5. The molecule of claim 1 , further comprising a human heavy chain variable CDR2 region, the CDR2 region consisting of the amino acid sequence IPIFGT (SEQ ID NO: 8) and a human heavy chain variable CDR1 region, the CDR1 region consisting of the amino acid sequence GGTFSSY (SEQ ID NO: 9).
6. The molecule of claim 1 , wherein the molecule is an IgG1 molecule.
7. The molecule of claim 1 , further comprising a fluorescent label.
8. The molecule of claim 1 , further comprising a human heavy chain variable region consisting of the amino acid sequence of SEQ ID NO: 10.
9. The molecule of claim 1 , further comprising a human light chain variable region consisting of the amino acid sequence of SEQ ID NO: 11.
10. A molecule that binds to Ep-CAM, comprising a human heavy chain variable region comprising a CDR3 region consisting of the amino acid sequence DPFLHY (SEQ ID NO: 6) and a human light chain variable region comprising a CDR1 region consisting of an amino acid sequence of RASQTISNNYLA (SEQ ID NO: 12) or RASOSVSSSYLA (SEQ ID NO: 13).
11. An antibody that binds to Ep-CAM, wherein the human heavy chain variable CDR3 region has an amino acid sequence consisting of SEQ ID NO: 6.
12. The antibody of claim 11 , further comprising a human light chain variable CDR3 region having the amino acid sequence consisting of SEQ ID NO: 7.
13. The antibody of claim 11 , characterized in that the antibody has an affinity constant for human Ep-CAM that is less than 5.0 nM.
14. The antibody of claim 11 , characterized in that the antibody has an affinity constant for human Ep-CAM that is between 5.0 nM and 0.4 nM.
15. The antibody of claim 11 , further comprising a human heavy chain variable CDR2 region having the amino acid sequence consisting of SEQ ID NO: 8 and a human heavy chain variable CDR1 region having the amino acid sequence consisting of SEQ ID NO: 9.
16. The antibody of claim 11 , wherein the antibody is an IgG1.
17. The antibody of claim 11 , further comprising a fluorescent label.
18. The antibody of claim 11 , further comprising a human heavy chain variable region having the amino acid sequence consisting of SEQ ID NO: 10.
19. The antibody of claim 11 , further comprising a human light chain variable region comprising a CDR1 region having an amino acid sequence consisting of SEQ ID NO: 12 or SEQ ID NO: 13.
20. The antibody of claim 11 , further comprising a human light chain variable region having the amino acid sequence consisting of SEQ ID NO: 11.